Fibrolamellar Cancer Foundation Research Grant Program

About this program

The Fibrolamellar Cancer Foundation (FCF) funds innovative research aimed at improving understanding, diagnosis, epidemiology, and treatment of fibrolamellar carcinoma (FLC), particularly projects with potential to advance novel therapies or clinical trials toward a cure. Applicants must be employed by institutions engaged in health-related research, and proposals must focus specifically on FLC. FCF requires collaboration and open sharing of data and resources, with applications reviewed three times annually by March 1, July 1, and November 1; funded researchers must submit semiannual financial and scientific progress reports.